Sérgio D. Simon

2.3k total citations
46 papers, 773 citations indexed

About

Sérgio D. Simon is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sérgio D. Simon has authored 46 papers receiving a total of 773 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 14 papers in Cancer Research and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sérgio D. Simon's work include Breast Cancer Treatment Studies (10 papers), Advanced Breast Cancer Therapies (7 papers) and Colorectal Cancer Treatments and Studies (6 papers). Sérgio D. Simon is often cited by papers focused on Breast Cancer Treatment Studies (10 papers), Advanced Breast Cancer Therapies (7 papers) and Colorectal Cancer Treatments and Studies (6 papers). Sérgio D. Simon collaborates with scholars based in Brazil, United States and United Kingdom. Sérgio D. Simon's co-authors include Carlos H. Barrios, Dianne M. Finkelstein, Paul E. Goss, Miguel Srougi, Brittany Lee, Rene Claúdio Gansl, Artur Katz, José Bines, Séverine Sarp and Everardo D. Saad and has published in prestigious journals such as Nature, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Sérgio D. Simon

42 papers receiving 749 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sérgio D. Simon Brazil	14	506	186	173	155	140	46	773
Jacques Camerlo France	18	448 0.9×	190 1.0×	162 0.9×	172 1.1×	61 0.4×	50	932
Maria Del Pilar Estevez-Diz Brazil	20	553 1.1×	187 1.0×	148 0.9×	312 2.0×	254 1.8×	82	1.2k
G. Schubert-Fritschle Germany	16	485 1.0×	185 1.0×	217 1.3×	164 1.1×	168 1.2×	58	847
Judith Offman United Kingdom	16	341 0.7×	108 0.6×	170 1.0×	184 1.2×	143 1.0×	30	806
S. Jezdic Italy	9	316 0.6×	319 1.7×	233 1.3×	144 0.9×	85 0.6×	15	795
René Aloísio da Costa Vieira Brazil	15	392 0.8×	246 1.3×	68 0.4×	135 0.9×	148 1.1×	63	721
Serafina Mammoliti Italy	17	439 0.9×	75 0.4×	143 0.8×	96 0.6×	157 1.1×	50	841
Sudha Sundar United Kingdom	21	373 0.7×	176 0.9×	134 0.8×	243 1.6×	317 2.3×	103	1.5k
Thomas J. Herzog United States	17	377 0.7×	151 0.8×	83 0.5×	260 1.7×	138 1.0×	95	924
Jeffrey Schneider United States	15	592 1.2×	86 0.5×	160 0.9×	132 0.9×	120 0.9×	40	882

Countries citing papers authored by Sérgio D. Simon

Since Specialization

Citations

This map shows the geographic impact of Sérgio D. Simon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sérgio D. Simon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sérgio D. Simon more than expected).

Fields of papers citing papers by Sérgio D. Simon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sérgio D. Simon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sérgio D. Simon. The network helps show where Sérgio D. Simon may publish in the future.

Co-authorship network of co-authors of Sérgio D. Simon

This figure shows the co-authorship network connecting the top 25 collaborators of Sérgio D. Simon. A scholar is included among the top collaborators of Sérgio D. Simon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sérgio D. Simon. Sérgio D. Simon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Werutsky, Gustavo, Juliana Giacomazzi, Daniela Dornelles Rosa, et al.. (2024). The impact of a breast cancer diagnosis on marital outcomes and factors associated with divorce and separation. Revista Brasileira Ginecologia e Obstetrícia. 46.

Assad, Daniele Xavier, Flávia Paes, André Mattar, et al.. (2024). Real-World Evidence of Ribociclib Plus Aromatase Inhibitors as First-Line Treatment in Advanced Breast Cancer: The BrasiLEEira Study. JCO Global Oncology. 10(10). e2300484–e2300484.

Aguiar‐Ibáñez, Raquel, et al.. (2023). CO208 Recurrence Rates and Survival Among Patients with Early-Stage Cancers: A Systematic Literature Review. Value in Health. 26(6). S54–S54. 2 indexed citations

Werutsky, Gustavo, Geraldo Silva Queiroz, Sérgio D. Simon, et al.. (2022). Time interval between diagnosis to treatment of breast cancer and the impact of health insurance coverage: a sub analysis of the AMAZONA III Study (GBECAM 0115). Breast Cancer Research and Treatment. 198(1). 123–130. 4 indexed citations

Dawood, Shaheenah, Rebecca Dent, Sung‐Bae Kim, et al.. (2021). Optimizing treatment selection, and sequencing decisions for Management of HR-Positive, HER2-Negative advanced breast cancer – Proceedings from breast cancer expert group meeting. BMC Proceedings. 15(S10). 15–15. 2 indexed citations

Dawood, Shaheenah, et al.. (2020). Optimizing the management of HER2-negative metastatic breast cancer in the era of PARP inhibitors—proceedings from breast cancer expert group meeting. Chinese Clinical Oncology. 9(5). 61–61. 3 indexed citations

Simon, Sérgio D., et al.. (2019). Prevalence and risk factors of medication-related osteonecrosis of the jaw in osteoporotic and breast cancer patients: a cross-sectional study. Supportive Care in Cancer. 28(5). 2265–2271. 17 indexed citations

Simon, Sérgio D., Zhiming Jin, Zhihong Xu, et al.. (2018). Efficient Synthesis of Glutamate Peptide-Estradiol Conjugate for Imaging Estrogen Receptor-Positive Diseases. BioMed Research International. 2018. 1–14. 4 indexed citations

Sonnenblick, Amir, Dominique Agbor‐Tarh, Ian Bradbury, et al.. (2017). Impact of Diabetes, Insulin, and Metformin Use on the Outcome of Patients With Human Epidermal Growth Factor Receptor 2–Positive Primary Breast Cancer: Analysis From the ALTTO Phase III Randomized Trial. Journal of Clinical Oncology. 35(13). 1421–1429. 106 indexed citations

10.

Usón, Pedro Luiz Serrano, et al.. (2017). Incidental Findings in Reduction Mammoplasty Specimens in Patients with No Prior History of Breast Cancer. An Analysis of 783 Specimens. Pathology & Oncology Research. 24(1). 95–99. 13 indexed citations

11.

Liedke, Pedro Emanuel Rubini, Dianne M. Finkelstein, Jackie Szymonifka, et al.. (2013). Outcomes of Breast Cancer in Brazil Related to Health Care Coverage: A Retrospective Cohort Study. Cancer Epidemiology Biomarkers & Prevention. 23(1). 126–133. 71 indexed citations

12.

Lee, Brittany, et al.. (2012). Breast cancer in Brazil: present status and future goals. The Lancet Oncology. 13(3). e95–e102. 130 indexed citations

13.

Buzaid, Antônio C., Sérgio D. Simon, Luis Fein, et al.. (2010). Cetuximab Plus Irinotecan in Pretreated Metastatic Colorectal Cancer Progressing on Irinotecan: The LABEL Study. Clinical Colorectal Cancer. 9(5). 282–289. 10 indexed citations

14.

Saad, Everardo D., et al.. (2010). Further evidence of the prognostic role of pretreatment levels of CA 19-9 in advanced pancreatic cancer. Revista da Associação Médica Brasileira. 56(1). 22–26. 2 indexed citations

15.

Robertson, J.F.R., Guenther G. Steger, P. Neven, et al.. (2009). Activity of fulvestrant in HER2-overexpressing advanced breast cancer. Annals of Oncology. 21(6). 1246–1253. 20 indexed citations

16.

Hamerschlak, Nelson, et al.. (2006). Imatinib improves survival of CML patients in accelerated phase: A 48-month follow-up. SHILAP Revista de lepidopterología. 1 indexed citations

17.

Steger, Guenther G., Sérgio D. Simon, Aňa Lluch, et al.. (2005). Fulvestrant (‘Faslodex’): Clinical experience from the Compassionate Use Programme. Cancer Treatment Reviews. 31. S10–S16. 18 indexed citations

18.

Saad, Everardo D., Marcel Cerqueira César Machado, Dalia Wajsbrot, et al.. (2002). Pretreatment CA 19-9 Level as a Prognostic Factor in Patients with Advanced Pancreatic Cancer Treated with Gemcitabine. International Journal of Gastrointestinal Cancer. 32(1). 35–42. 81 indexed citations

19.

Reverdy, Céline, et al.. (2001). The protein-protein interaction map of Helicobacter pylori (vol 409, pg 211, 2001). Nature. 409(6821). 743–743. 1 indexed citations

20.

Katz, Artur, Rene Claúdio Gansl, Sérgio D. Simon, et al.. (1991). Phase II Trial of Etoposide (V), Adriamycin (A), and Cisplatinum (P) in Patients with Metastatic Gastric Cancer. American Journal of Clinical Oncology. 14(4). 357–358. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact